Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹396.80
1.45 (0.37%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹3.62K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
18.5
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹318.95+24.4%
52W High₹564.05-29.7%
Current Price
₹396.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹317.44
Upper Circuit₹476.16
Reference Price
₹396.80
Investment Checklist
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹386.75
Cup and Handle on 1W — target ₹473.15
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Composite score -21.73 (SELL) with 74.9% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
75%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
381.98
EMA50
377.41
EMA200
407.93
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs3
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹402.45
₹407.20
₹423.75
₹464.38
₹476.50
Support (Below)
₹376.50
₹364.54
₹356.20
₹343.85
₹325.60
Volume Analysis
TrendSTABLE
Change+4.20%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹392.83
3% Risk₹384.90
5% Risk₹376.96
7% Risk (Custom)
₹369.02Technical Levels
1x ATR (Volatility)₹384.79
2x ATR (Swing)₹372.78
3x ATR (Trend)₹360.77
Immediate Support₹376.50
Moving Averages
EMA 9 (Short-term)₹387.09
EMA 20 (Medium-term)₹381.98
EMA 50 (Trend)₹377.41
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹658.7 Cr | ₹590.5 Cr | ₹652.8 Cr | ₹601.7 Cr |
| Net Profit | ₹62.9 Cr | ₹53.9 Cr | ₹45.3 Cr | ₹40.5 Cr |
| EPS | — | ₹5.91 | ₹4.95 | ₹4.44 |
| Operating Profit | ₹95.2 Cr | ₹74.4 Cr | ₹84.4 Cr | ₹56.3 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Aarti Drugs Limited | ₹396.80 | +0.37% | 18.5 | ₹3.62K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 09 Feb 2026 | Interim Dividend - Rs 2 Per Share | INTERIM_DIVIDEND |
| 04 Feb 2025 | Interim Dividend - Re 1 Per Share | INTERIM_DIVIDEND |
| 05 Sept 2024 | Buy Back | BUYBACK |
| 06 Feb 2024 | Interim Dividend - Re 1 Per Share | INTERIM_DIVIDEND |
| 04 Aug 2023 | Buy Back | BUYBACK |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for AARTIDRUGS
View All
neutral
CNBC TV18 - Markets 54d ago
Eight Pharma stocks that should be on your radar on Monday
Pharmaceutical companies reported a slew of updates over the weekend. Earnings reactions from KIMS, Global Health, Gland Pharma, Aarti Drugs, to a USFDA observation list for Emcure Pharma, these are the drugmakers that should be on your radar today.
AARTIDRUGSAARTIINDEMCUREGLANDGLOBALKIMSMEDANTAChemicalsConsumer Services
NEWS
positive
Business Standard - Markets 56d ago
Aarti Drugs consolidated net profit declines 12.20% in the March 2026 quarter
Sales rise 6.43% to Rs 720.30 crore
AARTIDRUGSAARTIINDChemicalsHealthcare
positive
CNBC TV18 - Markets 56d ago
Aarti Drugs Q4 profit falls 12% despite revenue growth
Revenue rises 6.4% year-on-year; EBITDA margin remains largely stable
AARTIDRUGSAARTIINDMOGSECChemicalsFinancial Services